The new thimerosal study published in Pediatrics leaves a lot of open questions. So does the response to the study by the Editor-in-Chief of the journal, Dr. Lewis First.
In his blog introducing the study, Dr. First wrote that, "You'll be reassured that the results show essentially no differences between groups who did or did not get thimerosal in their vaccines-and you'll want to know this information when talking with parents of your patients about the safety and benefits of vaccines."
But that made no sense. The study clearly stated that all children received thimerosal in the first year of life - some got 62.5 micrograms and the rest got 137.5 mcg. But there were no children who "did not get thimerosal," as Dr. First urged America's pediatricians to tell parents.
I thought I would write to AAP and clear things up, and see if a correction would be run. Officials there were (and have been) courteous, respectful and professional. So I sent the following email to the press office of the Academy: